Alprenolol in hypertension.
D000368:Aged; D000526:Alprenolol / Q000009:adverse effects / Q000627:therapeutic use*; D001581:Benzothiadiazines; D002752:Chlorthalidone / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004070:Digitalis / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006333:Heart Failure / Q000139:chemically induced / Q000188:drug therapy; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D008750:Methyldopa / Q000627:therapeutic use; D008517:Phytotherapy; D010919:Placebos; D010946:Plants, Medicinal; D010947:Plants, Toxic; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D013997:Time Factors
D001581:Benzothiadiazines; D004232:Diuretics; D010919:Placebos; D049993:Sodium Chloride Symporter Inhibitors; D006830:Hydralazine; D008750:Methyldopa; D000526:Alprenolol; D002752:Chlorthalidone